Did The US FDA Mix Politics And Science With Its Cancer Guidance Announcement?
Three new guidances were announced the morning of President Biden’s State of the Union address, but experts said the move did not equate with past White House pressure on agency decisions.
You may also be interested in...
The president’s state of the union address comes after a year of mostly disappointing efforts for the administration on COVID and drug pricing.
New FDA commissioner commitment to counter misinformation also appears to include pledge to ensure agency is driven by science-based decisions, not politics.
Instead of waiting until after regulatory events like COVID boosters and Aduhelm, FDA should describe its decision-making process along the way to help restore public faith in the agency, former deputy commissioner Josh Sharfstein says.